A Clinical Trial Investigating the Comparison of Three Different Concentrations of NN9535 in Healthy Male Subjects

Inclusion criteria

• Healthy male subjects, based on an assessment of medical history, physical examination and clinical laboratory data at screening, as determined by the Investigator
• Body weight between 80 kg and 110 kg (both inclusive)
• Body Mass Index (BMI) between 18 and 27 kg/m2, both inclusive
• Fasting plasma glucose max 108 mg/dl (6.0 mmol/l)

Exclusion criteria

• Known or suspected allergy to trial product(s) or related products
• Previous participation in this trial (randomisation)
• The receipt of any investigational medicinal product within 3 months prior to this trial
• Subjects who have had a clinically relevant illness within 4 weeks of dosing
• History of or presence of cancer, diabetes, or any clinically relevant cardiovascular, respiratory, metabolic, renal, hepatic, gastrointestinal, endocrinological, haematological, dermatological, venereal, neurological, psychiatric diseases or other major disorders
• Regular smoking as defined by smoking 1 or more cigarettes or the equivalent amount of tobacco pr day, and unable to refrain from smoking during the entire confinement period